Top compounds associated with response to IRF2BPL


Feature Type Standardized
Nominal ANOVA
mRNA JW-480 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA TAE684 CCLE pan-cancer AAC 0.14 0.004
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.099 0.004
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.005
mRNA BX-912 GDSC1000 pan-cancer AAC -0.094 0.005
mRNA XL-184 GDSC1000 pan-cancer AAC -0.11 0.005
mRNA BRD-K11533227 CTRPv2 pan-cancer AAC -0.11 0.005
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.005
mRNA BHG712 GDSC1000 pan-cancer AAC -0.092 0.005
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.14 0.006
Download CSV